Sherbrooke Park Advisers LLC Pulmonx Corp Transaction History
Sherbrooke Park Advisers LLC
- $215 Billion
- Q3 2025
Shares
1 transactions
Others Institutions Holding LUNG
# of Institutions
114Shares Held
31.3MCall Options Held
20.7KPut Options Held
0-
Primecap Management CO Pasadena, CA4.96MShares$7.39 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.62MShares$5.39 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$3.97 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.24MShares$3.34 Million0.0% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY1.26MShares$1.88 Million0.01% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $55.5M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...